NeoGenomics, Inc. (NEO): Price and Financial Metrics
NeoGenomics, Inc. (NEO)
Today's Latest Price: $36.31 USD
0.20 (0.55%)
Updated Jul 9 6:55pm
Add NEO to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 58 in Medical - Diagnostics/Research
See all "A" rated Strong Buy stocks
NEO Stock Summary
- With a one year PEG ratio of 121,831.8, Neogenomics Inc is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 99.96% of US stocks.
- NEO's current price/earnings ratio is 1,101.87, which is higher than 99.65% of US stocks with positive earnings.
- Price to trailing twelve month operating cash flow for NEO is currently 367.89, higher than 99.1% of US stocks with positive operating cash flow.
- If you're looking for stocks that are quantitatively similar to Neogenomics Inc, a group of peers worth examining would be LSBK, MLAB, UCTT, SBAC, and MOBL.
- NEO's SEC filings can be seen here. And to visit Neogenomics Inc's official web site, go to www.neogenomics.com.
NEO Daily Price Range
NEO 52-Week Price Range
NEO Stock Price Chart Technical Analysis Charts
NEO Price/Volume Stats
| Current price | $36.31 | 52-week high | $36.80 |
| Prev. close | $36.11 | 52-week low | $18.52 |
| Day low | $35.90 | Volume | 824,500 |
| Day high | $36.80 | Avg. volume | 1,040,357 |
| 50-day MA | $28.65 | Dividend yield | N/A |
| 200-day MA | $27.18 | Market Cap | 3.82B |
NeoGenomics, Inc. (NEO) Company Bio
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories providing genetic and molecular testing services to hospitals, pathologists, oncologists, urologists, other clinicians and researchers, and other laboratories in the United States. The company was founded in 2001 and is based in Fort Myers, Florida.
Loading social stream, please wait...